Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank Value Type Network Comparison Type green description Interaction Map red network_comparison Filtered
Results: HTML CSV LaTeX
Showing element 2680 to 2729 of 16578 in total
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
244.534\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
gtp-binding nuclear protein ran (tc4) (ran gtpase) (androgen receptor- associated protein 24). [source:swissprot;acc:p17080]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.601\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.933\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
nucleotide-binding protein 1 (nbp 1). [source:swissprot;acc:p53384]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05688\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
200.582\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
integrin beta-1 precursor (fibronectin receptor beta subunit) (cd29 antigen) (integrin vla-4 beta subunit). [source:swissprot;acc:p05556]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.277\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02839\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.095\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytochrome p450 3a5 (ec 1.14.14.1) (cypiiia5) (p450-pcn3). [source:swissprot;acc:p20815]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
203.702\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.607\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
244.534\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
presenilin-like protein 1 (ec 3.4.99.-) (sppl2b protein). [source:swissprot;acc:q8tct7]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.601\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.933\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.116\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytochrome p450 3a7 (ec 1.14.14.1) (cypiiia7) (p450-hfla). [source:swissprot;acc:p24462]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.727\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02832\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05688\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.663\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.263\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.6\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.996\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.604\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02832\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.355\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.497\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.152\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytochrome p450 3a4 (ec 1.14.13.67) (quinine 3-monooxygenase) (cypiiia4) (nifedipine oxidase) (nf-25) (p450-pcn1). [source:swissprot;acc:p08684]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.747\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.595\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.174\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
enteropeptidase precursor (ec 3.4.21.9) (enterokinase). [source:swissprot;acc:p98073]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.81\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0283\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.355\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.497\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.613\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1b subunit (sigma-adaptin 1b) (adaptor protein complex ap-1 sigma-1b subunit) (golgi adaptor ha1/ap1 adaptin sigma-1b subunit) (clathrin assembly protein complex 1 sigma- 1b small chain) (sigma 1b subunit of ap-1 clathrin) (dc22). [source:swissprot;acc:p56377]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.207\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.594\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.095\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytochrome p450 3a5 (ec 1.14.14.1) (cypiiia5) (p450-pcn3). [source:swissprot;acc:p20815]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.702\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0283\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.355\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.497\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.233\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
pre-mrna processing factor 31 homolog; pre-mrna processing factor 31 homolog (yeast). [source:refseq;acc:nm\_015629]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.821\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.588\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.124\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor (ec 3.6.1.23) (dutpase) (dutp pyrophosphatase). [source:swissprot;acc:p33316]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.698\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02828\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
245.613\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.469\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05654\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.907\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.493\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.586\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
257.636\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ribosomal protein p0-like protein; 60s acidic ribosomal protein po; ribosomal protein, large, p0-like. [source:refseq;acc:nm\_016183]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
245.84\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.796\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.339\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
protein ad-016 (protein cgi-116) (x0009). [source:swissprot;acc:q9y3c0]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.03\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02827\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
216.745\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm4 (glycine-rich protein) (grp). [source:swissprot;acc:q9y4z0]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05628\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.124\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor (ec 3.6.1.23) (dutpase) (dutp pyrophosphatase). [source:swissprot;acc:p33316]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.698\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.574\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
233.483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
245.246\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.763\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.152\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytochrome p450 3a4 (ec 1.14.13.67) (quinine 3-monooxygenase) (cypiiia4) (nifedipine oxidase) (nf-25) (p450-pcn1). [source:swissprot;acc:p08684]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.747\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02824\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05609\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.601\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1a subunit (sigma-adaptin 1a) (adaptor protein complex ap-1 sigma-1a subunit) (golgi adaptor ha1/ap1 adaptin sigma-1a subunit) (clathrin assembly protein complex 1 sigma- 1a small chain) (clathrin coat assembly protein ap19) (ha1 19 kda subunit) (sigma 1a subunit of ap-1 clathrin). [source:swissprot;acc:q00382]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.169\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.568\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.405\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.135\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.73\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
192.974\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
glioma-amplified sequence-41; numa binding protein 1. [source:refseq;acc:nm\_006530]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.424\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02824\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
205.793\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
receptor protein-tyrosine kinase erbb-4 precursor (ec 2.7.1.112) (p180erbb4) (tyrosine kinase-type cell surface receptor her4). [source:swissprot;acc:q15303]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
211.36\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.567\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.693\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
190.844\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
putative alpha-mannosidase c20orf31 precursor (ec 3.2.1.-). [source:swissprot;acc:q9bv94]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.228\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02821\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
205.793\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
receptor protein-tyrosine kinase erbb-3 precursor (ec 2.7.1.112) (c-erbb3) (tyrosine kinase-type cell surface receptor her3). [source:swissprot;acc:p21860]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
211.36\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.567\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
213.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
225.293\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.653\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
200.462\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.115\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0282\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.974\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
interferon-related developmental regulator 1 (nerve growth factor- inducible protein pc4). [source:swissprot;acc:o00458]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
204.538\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.564\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
208.987\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
220.593\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.606\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
198.663\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.263\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02819\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.059\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
200.62\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.561\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
234.458\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
upf0202 protein kiaa1709. [source:swissprot;acc:q9h0a0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
246.055\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.597\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/